News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Merck and Siemens Strengthen Partnership to Drive AI and Data-Led Drug Development
Wednesday, September 24, 2025Merck a global science and technology company has expanded its strategic partnership with Siemens through a new Memorandum of Understanding MoU The agreement aims to accelerate digital transformation
TegMine Therapeutics Collaborates with Boehringer Ingelheim to Advance 2-Factor Antibody System for Cancer
Wednesday, September 24, 2025TegMine Therapeutics a biotechnology company specialising in precision oncology has entered a research and development collaboration with Boehringer Ingelheim The partnership will use TegMines proprietary Factor Antibody System
Sanofi’s SAR446268 Therapy Receives US Fast Track Designation for Non-Congenital Myotonic Dystrophy Type 1
Tuesday, September 23, 2025The US Food and Drug Administration FDA has granted Fast Track designation to SAR Sanofis AAV gene therapy for juvenile and adult noncongenital myotonic dystrophy type DM The Fast Track process is designed to accelerate the development and review of...
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
Friday, September 19, 2025Minovia Therapeutics Ltd a clinicalstage biotechnology company focused on therapies for mitochondrial diseases and agerelated decline has received Fast Track Designation FTD from the US Food and Drug Administration
Roche signs merger agreement to acquire 89bio and its phase 3 FGF21 analogue for moderate to severe MASH
Thursday, September 18, 2025Roche has entered into a definitive merger agreement to acquire bio Inc a Nasdaqlisted clinicalstage biopharmaceutical company developing therapies for liver and cardiometabolic diseases The deal is expected to close in the fourth quarter of
Thryv Therapeutics secures FDA IND clearance for THRV-1268 in Long QT Syndrome
Thursday, September 18, 2025Thryv Therapeutics Inc a clinicalstage biotechnology company developing serum glucocorticoid inducible kinase SGK inhibitors for cardiovascular diseases has received clearance from the US Food
Anti-MTBR Tau Antibody Etalanetug Receives FDA Fast Track Designation
Wednesday, September 17, 2025Eisai Co Ltd has announced that etalanetug development code E an investigational antiMTBR microtubule binding region tau antibody has been granted Fast Track designation by the US Food and Drug Administration
VarmX Enters Strategic Collaboration and Option Agreement with CSL to Advance Novel Coagulation Treatment
Wednesday, September 17, 2025VarmX a biotechnology company focused on therapies for bypassing direct oral anticoagulants targeting activated factor Xa FXa DOACs and inherited coagulation disorders has formed
Corstasis Therapeutics Gains FDA Approval for ENBUMYST™ (Bumetanide Nasal Spray) to Treat Edema Linked to Heart, Liver and Kidney Disease
Tuesday, September 16, 2025Corstasis Therapeutics has received approval from the US Food and Drug Administration FDA for ENBUMYST bumetanide nasal spray The treatment is indicated for oedema linked to congestive heart failure CHF
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
Tuesday, September 16, 2025Parexel a global clinical research organisation CRO has formed a strategic partnership with Paradigm Health to transform how clinical trials are designed and executed The collaboration aims to accelerate
